Summary 3'P nuclear magnetic resonance (NMR) spectra of cells and of cell extracts revealed high levels of phosphorylcholine (PC) and phosphocreatine (PCr) in an adriamycin-resistant human small cell lung carcinoma cell line (GLC4/ADR) and the adriamycin-sensitive parental cell line (GLC4). PCr levels in extracts of GLC4/ADR were increased compared to extracts of GLC4. We estimated that 11% of the total intracellular ATP is not bound to Mg2" in both cell lines. This value corresponded to an intracellular free Mg2" of 0.30 mM. The effects of different adriamycin concentrations, 0.05, 1 and 30 JLM for GLC4 and 1, 30 and 200 LM for GLC4/ADR, on the phosphorus metabolite levels in continuously perfused cells were monitored.
glycoprotein is overexpressed (Riordan & Ling, 1985; Pastan & Gottesman, 1987) . This P-glycoprotein functions as a energy-dependent efflux pump to different types of antitumour drugs (Riordan & Ling, 1985; Horio et al., 1988) . Increased free radical detoxification could also play a role in adriamycin-resistance of these cells (Batist et al., 1986; Sinha et al., 1987) . Since both mechanisms are associated with energy-dependent processes, expressing the MDR phenotype may involve changes in energy requirements and energy metabolism. These changes have actually been observed in an adriamycin-resistant human breast cancer cell line (Cohen et al., 1986; Yeh et al., 1987; Lyon et al., 1988) . Cell lines resistant to epipodophyllotoxins, ellipticine and m-AMSA have also been established which do not overexpress the P-glycoprotein (Glisson et al., 1986; Estey et al., 1987; Pommier et al., 1986; Beck et al., 1987; Ferguson et al., 1988) . Cross resistance to other drugs is still observed and sometimes drug accumulation is decreased. It is unknown whether this so-called atypical MDR (Beck et al., 1987 ) is accompanied by changes in energy requirements and energy metabolism.
In order to obtain biochemical characteristics for the atypical MDR phenotype we focussed on metabolites of both energy metabolism (PCr, ATP and Pi) and phospholipid metabolism (GPC, PE and PC) in an adriamycin-sensitive small cell lung carcinoma cell line (GLC4) and an adriamycin-resistant subline (GLC4/ADR), which exhibits the atypical MDR phenotype (Zijlstra et al., 1987a; De Jong et al., 1990) . Phosphorus metabolite levels in living cells can be monitored by 31P NMR spectroscopy. So far, studies on the effect of adriamycin exposure on energy and lipid metabolism using 31P NMR were only done in in vivo models of murine mammary 16/C and murine mammary 17/C adenocar-cinomas (Evanochko et al., 1983; Evelhoch et al., 1987) . In vitro studies on cells using NMR spectroscopy necessitate trapping a dense cell suspension in a small volume. We have used the method described by Cohen et al. (1986) in which cells were embedded in agarose gel threads (Foxall & Cohen, 1983; Knop et al., 1984) . They have applied their technique using 31P and 13C NMR spectroscopy to various cell lines (Cohen et al., 1986; Lyon et al., 1988; Daly et al., 1987) . In their studies with small cell lung cancers the signal intensities of PCR did not change relative to the ATP signal intensities for over 24 h (Knop et al., 1987) .
In the present study, 31P and 'H NMR spectroscopy was employed to monitor levels of energy and phospholipid metabolism in GLC4 and GLC4/ADR cells. The effect of adriamycin on these levels were monitored in continuously perfused cells using 31P NMR spectroscopy. The presence of phosphorus metabolites characteristic for atypical MDR and the presence of response-specific markers of adriamycinsensitivity and -resistance are discussed. (Zijlstra et al., 1987a) . GLC4/ADR exhibited crossresistance to several other drugs (Zijlstra et al., 1987a; De Jong et al., 1990; Meijer et al., 1987) , while the Pglycoprotein was not overexpressed in GLC4/ADR (De Jong et al., 1990) . Prior to experimental use, GLC4/ADR was cultured without adriamycin for 20 days, at which time the resistance factor was maximal (Meijer et al., 1987) . Both cell lines grow partly attached, partly floating and were cultured in RPMI 1640 medium supplemented with 10% FCS at 37°C in a humid atmosphere with 5% CO2.
Materials and methods

Materials
Cell perfusion Cells (1-1.5 x 108) were resuspended in DME/F12 medium (pH 7.4) and 10% FCS. The perfusion system was prepared as described previously (Foxall & Cohen, 1983; Knop et al., 1984) with some modifications. Low-gelling agarose (0.8 ml in 0.9% NaCI) was added at 37°C to 1.6 ml of a cell suspension. Agarose strands were extruded under light pressure through a teflon capillary tube (0.5 mm inside diameter) immersed in an ice/water bath into an Wilmad MRS tube (1O mm inside diameter). The gel threads were perfused by aspiration (1.4 ml min-'). A low perfusion rate was used in this study, since the stability of the threads decreased in the presence of adriamycin. Consequently, the number of cells embedded in the threads had to be decreased to prevent partial acidification of the cells. A number of layers of nylon gauzes were used instead of a piece of sponge to restrain the threads, resulting in a higher perfusion capacity. The perfusate from a 200 ml reservoir consisted of DME/F12 and 10% FCS supplemented with penicillin (125 U/ml[') and streptomycin (125 U ml-'). Oxygen (95%) and CO2 (5%) were bubbled through the perfusate in the reservoir.
Cell extracts Cell extracts were made from 1-2 x 108 cells. The extraction procedure was performed at 4°C. Ice-cold perchloric acid (10%) was added to the pellet and the cell mixture was vortexed at the beginning and the end of a 20 min period. The extracts were neutralised with KOH, centrifuged to remove the KC104 precipitate, freeze-dried and redissolved in D20 (Evans & Kaplan, 1977 Since the relative separations between the P and a, and the and peaks of ATP are proportional to the amount of ATP bound to Mg2+, the fraction of total ATP that is not complexed to Mg2+ (0) can be calculated (Gupta & Moore, 1980a) . The free Mg2+ concentration can then be calculated using the dissociation constant of MgATP (ATP complexed to magnesium) (Kd= 38 gM) and the formula [Mg2]= Kd (0'-1 ) (Gupta & Moore, 1980a) .
Spectra of perfused cells were obtained 3 h after the perfusion was started, when no major changes in the spectra occurred. Two spectra were collected to estimate peak areas and peak heights at t = 0. Peak intensities of the different metabolites in spectra of cell extracts and in perfused cells were estimated by peak areas determined from computer simulated spectra using the deconvolution routine in the VXR-5000 software. Changes in the levels of the phosphorus metabolites in the presence or absence of adriamycin were estimated from resolution-enhanced spectra by comparing peak heights of the particular metabolite at different times. Peak heights of a given metabolite were expressed as a percent of the averaged peak height of this metabolite in the two spectra at t = 0. At lower fields an underlying 'hump' was absent in the spectra, which allowed the reliable and reproducible measurement of peak intensities. Using peak areas from resolution-enhanced spectra to estimate changes in metabolites did not give significantly different results.
Statistics
All results were expressed as means ± s.d. Statistical significance was determined by use of the Student's t-test.
Results
31P and 'H NMR spectra of cell extracts Cell extracts were made from adriamycin-sensitive (GLC4) and adriamycin-resistant (GLC4/ADR) cells. Assignments were made on basis of data in the literature (Daly et al., 1987; Evans & Kaplan, 1977; Evanochko et al., 1984) and by adding standard compounds. Extracts of both cell lines showed high levels of PC (1 in Figure la and b). Additional unidentified resonances could be seen, possibly AMP and PE, on the low field side of the PC peaks. Low levels of probably GPC (4) and GPE (3) could be detected in the extracts. High levels of PCr (5) were detected in both cell lines with highest PCr levels in the GLC4/ADR extracts (Table I) . Expanding the spectra revealed another triphosphate near the P resonances of ATP (11) that accounted for 25 ± 4% (s.d., n = 3) of the total peak area in GLC4/ADR extracts and for 19 ± 4% in GLC4 extracts. This triphosphate could be UTP, GTP or CTP (Evans & Kaplan, 1977; Evanochko et al., 1984) . High resolution 'H NMR spectra were obtained from extracts of both cell lines in D20. Figure 2 shows the results for GLC4. The identification of the peaks was made using previous assignments in tumour cell extracts and by adding standard compounds (Evanochko et al., 1984) . The most intense resonances originated from choline, PC, PCr and creatine; furthermore, lactate, acetate and amino acids (alanine, proline, glutamic acid and glutamine) were found. In the low field region of the 'H NMR spectra resonances from adenosine derivatives and some uracil-, guanine-and cytosine-containing compounds predominated. No major differences between spectra of GLC4 and GLC4/ADR were found.
31 P NMR spectra ofperfused cells Spectra of perfused GLC4 and GLC4/ADR cells at 37°C were recorded at a 2.25 s repetition rate and a 550 pulse angle to ensure almost complete spin relaxation of the metabolites (Figure 3 ). To estimate the relative levels of phosphorus metabolites in GLC4 and GLC4/ADR we determined peak areas of the various metabolites (Table II) in several spectra at t = 0 by computer simulation of the spectra using a deconvolution routine. Partially overlapping peaks could be separated using this program. The peak areas were expressed to that of the PATP (8) resonance. Peak areas of Pi (2) were not used, since Pi was also present in the medium we used.
Peak area of 'yATP (5) triphosphates might be present, cSome other triphosphates might be present, dp <0.025, GLC4 vs GLC4/ADR. catalysed by creatine kinase and adenylate kinase that are important for energy metabolism (Lawson & Veech, 1979) . The spectra of perfused cells we had used to quantify relative levels of metabolites were also used to estimate the fraction of total ATP not bound to Mg2+. This fraction was 0.11 ± 0.01 in GLC4/ADR and 0.11 ± 0.02 in GLC4 cells.
The free intracellular Mg2+ concentrations were calculated from these fractions as described in Materials and methods and were 0.32 ± 0.03 mM and 0.30 ± 0.06 mM in GLC4/ADR and GLC4. The total ADP concentration (MgADP and free ADP) can be calculated from ATP, PCr and Cr concentrations in extracts, the intracellular pH and the assumed equilibrium constant KCk of the creatine kinase reaction at this Mg2+ concentration according to Lawson et al. (1979) . (Figure 4b) . The standard deviations of PCr levels were rather large in adriamycin treated cells of both cell lines because the peak intensity was low and therefore more susceptible to noise.
Since the yATP and aATP resonances might contain some contributions from ADP, changes in height of the J3ATP resonance were used to determine the influence of adriamycin on ATP. ATP levels in untreated GLC4 cells increased to 140% of the initial value (t=4-15h, P<0.05 vs t=0) ( Figure Sa) . In the presence of 30 JAM adriamycin an increase to 175% of the initial ATP level was seen within 5 to 6 h (t = 2-7 h, P <0.025 vs control), which subsequently decreased to 20% at 15 h ( Figure Sa and 6a) . In untreated GLC4/ADR cells ATP levels increased to 125% of the initial value (t = 3-15 h, P <0.05 vs t = 0) ( Figure Sb The energy status of a cell could be described by the PCr/IJATP ratio. We averaged the results from Effect of adriamycin on phospholipid metabolite levels of perfused GLC4 and GLC4/ADR cells PC levels in untreated GLC4 cells increased to 170% of the initial value (t = 2-15 h, P < 0.05 vs control) (Figure 8a ). In the presence of 30 JAm adriamycin the level slowly dropped to 40% of the initial value (t = 5 -15 h, P < 0.005 vs control) (Figures 6a and 8a) . In untreated GLC4/ADR cells PC levels increased to 150% (t = 3 15 h, P <0.05 vs t =) (Figure 8b (Figures 3b and 6b) adriamycin was added to the perfusate. Ratios were obtained from peak heights of the metabolites in the 31p NMR spectra, as described in Materials and methods and Results.
PC was observed in cell extracts as well as intact cells (Figures 1-3) . The PE resonance was not present in the spectra, since these cells were grown in media without ethanolamine. However, these cells can still produce phosphatidylethanolamine by decarboxylation of phosphatidylserine (Daly et al., 1987; Ansell & Spanner, 1982) . Phospholipid analysis of our cell lines indeed revealed the presence of phosphatidylethanolamine (Zijlstra et al., 1987b) .
The presence of PC and PE in tumour cells might be of diagnostic value, since in vivo human tumours showed elevated levels of PC and PE compared to the tissue of origin (Daly & Cohen, 1989) .
In adriamycin-resistant MCF-7 breast cancer cells, PCr levels were increased, while PC, GPC, GPE and diphosphodiester levels were decreased compared to the ATP level (in the original report the PC and PE peaks were assigned to sugar phosphates) (Cohen et al., 1986) . NMR studies of other cell lines indicated that differences observed in metabolite levels did not correlate specifically with drugresistance (Evelhoch et al., 1987) . Decreased GPC, PC and PE levels were also observed in in vivo adriamycin-resistant 17/A adenocarcinomas, but as the untreated tumours progressed, the differences between the adriamycin-sensitive and -resistant tumours disappeared (Evelhoch et al., 1987) . Therefore, it is uncertain whether differences in phosphorus metabolite levels are related to the MDR or the atypical MDR phenotype. Both GLC4 and GLC4/ADR are anchorage-independent cell lines. Since an increase in PC could be related to an 4-c.
Discussion
31P NMR spectra from perfused cells and extracts showed the same resonances. Several cellular compartments have been described such as mitochondria that might influence the peak intensity of ,BATP (Gupta & Yushok, 1980b) . However, phosphorus metabolite content in cellular extracts as determined by "P NMR and biochemical analysis are in agreement (Desmoulin et al., 1986) . Furthermore, since spectral resolution was enhanced and complete relaxation of the phosphorus resonances spectra was obtained in our extracts, the significance of differences observed in peak areas relative to the PATP peak area is better indicated by comparing cell extracts. The relative PCr concentration was higher in extracts of GLC4/ADR compared to GLC4, however the ratio PCr/Cr was not changed. The percentage of unbound ATP and the intracellular Mg2" concentration were similar in intact GLC4 and GLC4/ADR cells. These results indicate that the equilibrium constant for the creatine kinase reaction and the equilibrium of this reaction are equal for both cell lines.
The calculated intracellular Mg"+ concentration of 0.3 mM was comparable with the intracellular Mg"+ concentration of 0.4 mM in Ehrlich ascites tumour cells (Gupta & Yushok, 1980b ). The relatively higher PCr level in GLC4/ADR could increase the capacity of these cells to maintain the ATP pool. In a previous report, high levels of PCr and low levels of disphosphodiester were observed in variant SCLC cell lines compared to classic SCLC cell lines (Knop et al., 1987 (Bessman & Carpenter, 1985) . An interesting finding was the effect of adriamycin treatment on the PC and GPC level only in GLC4/ADR cells. We could not confirm the increase in GPC levels in extracts. There are two possibilities. First, by using the continuous perfusion system GLC4/ADR cells were physically stressed resulting in an increase in phospholipid turnover that was stimulated by adriamycin treatment. Secondly, the peak we saw, was not due to GPC, but to a phospholipid component also resulting from an increased phospholipid turnover. In phospholipid synthesis, choline is converted to PC and further converted to phosphatidylcholine (Ansell & Spanner, 1982) . This phospholipid is degradaded to GPC and then to choline by glycerophosphocholine phosphodiesterase (EC 3.1.4.2) (Ansell & Spanner, 1982; Morash et al., 1988) . The increased phospholipid turnover might be related to the reduced adriamycin accumulation in GLC4/ADR cells. The reduced drug accumulation was not due to the increased activity of the P-glycoprotein (Zijlstra et al., 1987a; De Jong et al., 1990 ).
In human and rat neuroectodermal tumours ATP levels decreased strongly within 6 to 12 h after cyclophosphamide, vincristine and methotrexate treatment, while PCr levels remained undetactable (Naruse et al., 1985) . In MOPC 104E myeloma PCr/ATP ratio increased within 1 day after treatment with a curative dose of cyclophosphamide or 1,3-bis(2-chloroethyl)-l-nitrosourea, while PCr and ATP levels strongly reduced within 4 days (Ng et al., 1982) . In this study it was concluded, that the changed PCr/ATP ratio must partially reflect the effect of the chemotherapy on energy metabolism within the tumour cells. ATP/Pi and PCr/Pi ratios in adriamycin-sensitive mammary 17/A adenocarcinoma (Evelhoch et al., 1987) , in the RIF-1 fibrosarcoma and in GL gliosarcoma (Steen et al., 1988) were increased after adriamycin, cyclophosphamide and 1,3-bis(2-chloroethyl)-1 -nitrosourea treatment, respectively. The increase of these ratios after treatment was explained by reenergization of the tumour, while untreated control tumours in these studies showed declining ATP and PCr levels (Evelhoch et al., 1987; Li et al., 1988; Steen et al., 1988) . Untreated neuroectodermal tumours were still in an active stage which may explain the fast reduction in ATP levels 3 h after treatment with cyclophosphamide (300 mg kg-') (Naruse et al., 1985) , while an opposite effect of cyclophosphamide (300 mg kg-1) was seen in RIF-l fibrosarcoma . Untreated MOPC 104E myelomas were in a moderate active stage which may explain the slow decrease in ATP levels in 4 days (Ng et al., 1982) .
In our in vitro experiments the continuous perfused cells were supplied with sufficient nutrients. Therefore, these results showed without any interference from reenergization that adriamycin treatment had an effect on the energy metabolism in the adriamycin-sensitive GLC4 tumour cells which resulted in an increase of cellular ATP. The strong decrease in ATP and PCr levels after treatment were comparable with the effects of chemotherapy in in vivo tumours that were in a metabolic active stage (Ng et al., 1982; Naruse et al., 1985) . The same adriamycin concentration had no effect on ATP and PCr levels in the adriamycin-resistant GLC4/ADR tumour cells compared to untreated GLC4/ADR cells. No differences in phosphorus metabolites were observed in adriamycin treated and untreated adriamycin-resistant mammary 17/A adenocarcinoma, while adriamycin had a large effect on the adriamycin-sensitive tumour (Evelhoch et al., 1987) . To distinguish drug-sensitive from drug-resistant tumours in patients, it will be necessary to compare changes in phosphorus metabolite levels in tumours after treatment with an estimation of the changes in nucleoside triphosphates and PCr levels in this tumour that would occur without chemotherapeutic treatment, since the metabolic stage of a tumour probably determines the changes in phosphorus metabolites after chemotherapy. To obtain a reliable estimation, tissue heterogenity, tumour size, type of tumour, the glycolytic rate of the tumour, tumour hypoxia and the degree of vascularisation of a tumour have to be determined. Till now only a few often preliminary data are available on human tumour bioenergetics and responses to chemotherapy observed by NMR (Steen, 1989) . The continuous perfusion system can be used to study the relation between hypoxia and/or glucose deprivation and chemotherapeutic effectivity in in vitro experiments.
In conclusion, 31P NMR spectroscopy can be used in in vitro experiments to reveal biochemical markers for adriamycin-resistance and -sensitivity. However, much more in vitro and in vivo studies with drug-sensitive and drugresistant cells are necessary to obtain parameters to distinguish drug-sensitive from drug-resistant tumours in patients after chemotherapy by NMR spectroscopy.
